Join Gopi Shankar and several authors in Poster Forum #4 in the Solution Center (Exhibit Halls 3 & 4) for a conversation about posters on the topic, “Innovative methods in Formulations Development”, that he is especially excited about.
M0930-09-56 Excipient Screening of Long-Acting In Situ Forming Gels during Preclinical Formulation Development, Imogen Anastasiou, Pion Inc.
M1230-01-05 Rapid and Reproducible TAb/NAb anti-AAV Assays Across Serotypes and Species to Support Global Preclinical Programs, Quentin Osseman, Ph.D., Altasciences
M1130-07-41 Development and Verification of Novel Agarose Gel Based Dialysis Cassette System as an In Vitro Release Model for Long-Acting Injectable Formulations, Lakshmi Satwika Golagana, MS, AbbVie Inc.
M0930-07-44 Establish a Mucosa-Mimicking In Vitro Permeation Model for Evaluating Mucoadhesive Formulations, Yinglu (Lucy) Zhao, MS, Contract Pharmaceuticals Ltd.
M0930-09-59 Topical MEK Inhibitor Formulations Suppress HPV E6/E7 Expression and Promote Tumor Regression in Preclinical Models, Jason T. McConville, Ph.D., University of New Mexico
